PURPOSE: To develop an in silico model that provides an accurate prediction of the relative solubility of the lipophilic anticancer agent docetaxel in various excipients. MATERIALS AND METHODS: The in silico solubility of docetaxel in the excipients was estimated by means of the solubility (delta) and Flory-Huggins interaction (chi (FH)) parameters. The delta values of docetaxel and excipients were calculated using semi-empirical methods and molecular dynamics (MD) simulations. Cerius(2) software and COMPASS force-field were employed for the MD simulations. The chi (FH) values for the binary mixtures of docetaxel and excipient were also estimated by MD simulations. RESULTS: The values obtained from the MD simulations for the solubility of docetaxel in the various excipients were in good agreement with the experimentally determined values. The simulated values for solubility of docetaxel in tributyrin, tricaproin and vitamin E were within 2 to 6% of the experimental values. MD simulations predicted docetaxel to be insoluble in beta-caryophyllene and this result correlated well with experimental studies. CONCLUSIONS: The MD model proved to be a reliable tool for selecting suitable excipients for the solubilization of docetaxel.
PURPOSE: To develop an in silico model that provides an accurate prediction of the relative solubility of the lipophilic anticancer agent docetaxel in various excipients. MATERIALS AND METHODS: The in silico solubility of docetaxel in the excipients was estimated by means of the solubility (delta) and Flory-Huggins interaction (chi (FH)) parameters. The delta values of docetaxel and excipients were calculated using semi-empirical methods and molecular dynamics (MD) simulations. Cerius(2) software and COMPASS force-field were employed for the MD simulations. The chi (FH) values for the binary mixtures of docetaxel and excipient were also estimated by MD simulations. RESULTS: The values obtained from the MD simulations for the solubility of docetaxel in the various excipients were in good agreement with the experimentally determined values. The simulated values for solubility of docetaxel in tributyrin, tricaproin and vitamin E were within 2 to 6% of the experimental values. MD simulations predicted docetaxel to be insoluble in beta-caryophyllene and this result correlated well with experimental studies. CONCLUSIONS: The MD model proved to be a reliable tool for selecting suitable excipients for the solubilization of docetaxel.
Authors: Stephen K Tahir; Michael A Nukkala; Nicolette A Zielinski Mozny; R Bruce Credo; Robert B Warner; Qun Li; Keith W Woods; Akiyo Claiborne; Stephen L Gwaltney; David J Frost; Hing L Sham; Saul H Rosenberg; Shi-Chung Ng Journal: Mol Cancer Ther Date: 2003-03 Impact factor: 6.261
Authors: Robert Luxenhofer; Anita Schulz; Caroline Roques; Shu Li; Tatiana K Bronich; Elena V Batrakova; Rainer Jordan; Alexander V Kabanov Journal: Biomaterials Date: 2010-03-26 Impact factor: 12.479
Authors: Sun-Joo Lee; Paul H Schlesinger; Samuel A Wickline; Gregory M Lanza; Nathan A Baker Journal: J Phys Chem B Date: 2011-12-06 Impact factor: 2.991
Authors: Amritha G Nambiar; Maan Singh; Abhishek R Mali; Dolores R Serrano; Rajnish Kumar; Anne Marie Healy; Ashish Kumar Agrawal; Dinesh Kumar Journal: AAPS PharmSciTech Date: 2022-09-02 Impact factor: 4.026
Authors: Youssef Wahib Naguib; B Leticia Rodriguez; Xinran Li; Stephen D Hursting; Robert O Williams; Zhengrong Cui Journal: Mol Pharm Date: 2014-03-12 Impact factor: 4.939